Qatar Investment Authority

Tracked participation in 3 Atlas companies, with 0 explicitly attributed leads.

3portfolio companies

4round participations

0lead positions

Jan 2026latest activity

Capital activity

Portfolio

CompanyLatest valuationFirst → latestRoundsRoleAttributed partner

SSpaceXAIFrontierxAI (trading as SpaceXAI on its current website) is an AI frontier-lab building and deploying Grok-family…$230Bvaluation$52.1BraisedRecent roundsSeries E · Jan 2026$20B · Baron Capital Group, Cisco Investments +6Equity financing (round details/label not specified in source) · Sep 2025$10B · Kingdom Holding Co., Prince Al Waleed bin Talal +2Debt + strategic equity (reported as completed; not labeled as a numbered Series in the source) · Jun 2025$10B · Morgan StanleySpaceXAI$230BSep 2025 → Jan 20262 roundsParticipant—

ITIambic TherapeuticsScienceIambic Therapeutics (formerly Entos) is a clinical-stage life science and technology company developing…$8.4Mvaluation$476MraisedRecent roundsOversubscribed financing round (company described as >$100M) · Nov 2025$100M · Abingworth, Alexandria Venture Investments +15Series B extension (oversubscribed) · Jun 2024$50M · led by Exor Ventures, Mubadala CapitalSeries B (oversubscribed) · Oct 2023$100M · led by Abingworth, Ascenta CapitalIambic Therapeutics—Nov 2025 → Nov 20251 roundParticipant—

AAnthropic$183BSep 2025 → Sep 20251 roundParticipant—

DateCompanyRoundRaisedValuationRoleEvidence

Jan 06, 2026SSpaceXAIFrontierxAI (trading as SpaceXAI on its current website) is an AI frontier-lab building and deploying Grok-family…$230Bvaluation$52.1BraisedRecent roundsSeries E · Jan 2026$20B · Baron Capital Group, Cisco Investments +6Equity financing (round details/label not specified in source) · Sep 2025$10B · Kingdom Holding Co., Prince Al Waleed bin Talal +2Debt + strategic equity (reported as completed; not labeled as a numbered Series in the source) · Jun 2025$10B · Morgan StanleySpaceXAISeries E$20B$230BParticipant

Source ↗

Nov 10, 2025ITIambic TherapeuticsScienceIambic Therapeutics (formerly Entos) is a clinical-stage life science and technology company developing…$8.4Mvaluation$476MraisedRecent roundsOversubscribed financing round (company described as >$100M) · Nov 2025$100M · Abingworth, Alexandria Venture Investments +15Series B extension (oversubscribed) · Jun 2024$50M · led by Exor Ventures, Mubadala CapitalSeries B (oversubscribed) · Oct 2023$100M · led by Abingworth, Ascenta CapitalIambic TherapeuticsOversubscribed financing round (company described as >$100M)$100M—Participant

Source ↗

Sep 19, 2025SSpaceXAIFrontierxAI (trading as SpaceXAI on its current website) is an AI frontier-lab building and deploying Grok-family…$230Bvaluation$52.1BraisedRecent roundsSeries E · Jan 2026$20B · Baron Capital Group, Cisco Investments +6Equity financing (round details/label not specified in source) · Sep 2025$10B · Kingdom Holding Co., Prince Al Waleed bin Talal +2Debt + strategic equity (reported as completed; not labeled as a numbered Series in the source) · Jun 2025$10B · Morgan StanleySpaceXAIEquity financing (round details/label not specified in source)$10B$200BParticipant

Source ↗

Sep 02, 2025AAnthropicSeries F$13B$183BParticipant

Source ↗

DateCompanyRoundRaisedValuationRoleEvidence

Source ↗

Sep 02, 2025AAnthropicSeries F$13B$183BParticipant

Source ↗